« June 2006 | Main | August 2006 »

July 11, 2006

Study Links Exposure to Pesticides with Parkinson's Disease

The Scientific American reports that a Stanford University study has shown that individuals that have been habitually exposed to pesticides are 70% more likely to develop Parkinson's than those who haven't.

Unfortunately, it is not yet known which particular chemicals cause the increased risk;,although it has been made clear that exposure to asbestos, coal dust, exhaust, formaldehyde and radioactive material does not exhibit the same strong relationship. Although the cause of Parkinson's is not known, clearly one or more of the chemicals in pesticides can trigger the physiological effects of the disease. Parkinson's involves the progressive inability to produce dopamine, the neurotransmitter which, among other things, regulates muscle control.

Related Articles:

July 10, 2006

The Recent Spate of Flooding in the US May Create Hazardous Conditions

Many areas in the US have been victims of flooding in recent months, including parts of Texas and the Mid-Atlantic states, among others. Flooding can cause air and water contamination as well as provide the catalyst for the growth of toxic mold.

It is overwhelmingly important to be cautious of the dangers of returning to flooded environs. Usually flood water is contaminated with many different kinds of bacteria and sewage. Additionally, the air in one's home might be filled with noxious gases. Flood cleanup must involve the awareness of many safety concerns, especially the growth of toxic mold in the home and surrounding areas.

Related Articles:

July 07, 2006

Mesothelioma Treatment Denied to Afflicted in the UK

In an article published by the BBC, it was reported that The National Institute for Health and Clinical Excellence (NICE) in the UK has rejected the drug Alimta (Pemetrexed disodium) for the treatment of Mesothelioma.

The drug, which is used in the U.S. since being approved in 2004, is primarily used in cases of Mesothelioma caused by unintentional exposure to Asbestos. Among other reasons, NICE cited the prohibitive expense of the drug as being a factor for the disalllowance. The judgment has been widely criticized for putting sufferers in the UK at a disadvantage, especially since the drug is used prolifically from treatment across the border in Scotland.

Related Links: